• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CARDIOVASCULAR SYSTEMS, INC. DIAMONDBACK 360 CORONARY ORBITAL ATHERECTOMY SYSTEM; CORONARY ATHERECTOMY DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CARDIOVASCULAR SYSTEMS, INC. DIAMONDBACK 360 CORONARY ORBITAL ATHERECTOMY SYSTEM; CORONARY ATHERECTOMY DEVICE Back to Search Results
Model Number DBEC-125
Medical Device Problem Code Appropriate Device Problem Term/Code Not Available (3191)
Health Effect - Clinical Codes Chest Pain (1776); Death (1802); Perforation of Vessels (2135)
Date of Event 07/29/2020
Type of Reportable Event Death
Additional Manufacturer Narrative
The results of the investigation are inconclusive since the reported device was not returned for analysis.Based on the information received, the cause of the reported event could not be conclusively determined.The device history record for this oad lot number has been reviewed.No issues or discrepancies were noted during this review that would have contributed to the reported event.The device met material, assembly, and quality control requirements.(b)(4).
 
Event or Problem Description
A diamondback coronary orbital atherectomy device (oad) was selected for treatment of a lesion in the proximal right coronary artery.Several treatments were administered without issue.Throughout the procedure the patient experienced nausea and vomiting.Glideassist mode was used to successfully advance the oad to mid lesion, and several treatment passes were administered on low speed.Per the physician, it felt like the device had jumped, however this was not visibly seen on the angiogram.Imaging was performed, and no issues were noted.One more treatment pass was performed, and the oad stalled.The physician was advised to stop treatment and remove the device.Imaging revealed a vessel perforation, and the patient complained of chest pain.A balloon was inserted to tamponade the vessel, and a right ventricle infarction occurred as a result.The patient went into pulseless electrical arrest and coded.Advanced life support was administered for 40 (forty) minutes.A pericardial tap was performed, and a balloon pump was inserted.The patient was intubated.When the patient was stable, the perforation was re-assessed and confirmed to be sealed.The patient expired two (2) days later, due to the right ventricular infarction.In the opinion of the physician, the perforation was an outcome that they were prepared for, due to the tortuosity and severe calcium present in the vessel.In the opinion of the physician, the perforation was not related to the patient's death.The right ventricular infarction was caused by balloon expansion that was performed to tamponade the vessel.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DIAMONDBACK 360 CORONARY ORBITAL ATHERECTOMY SYSTEM
Common Device Name
CORONARY ATHERECTOMY DEVICE
Manufacturer (Section D)
CARDIOVASCULAR SYSTEMS, INC.
1225 old highway 8 nw
saint paul, mn
MDR Report Key10464672
Report Number3004742232-2020-00257
Device Sequence Number3120109
Product Code MCX
UDI-Device Identifier10852528005787
UDI-Public(01)10852528005787(17)211130(10)297025
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
P130005
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 08/28/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date11/30/2021
Device Model NumberDBEC-125
Device Catalogue Number70058-13
Device Lot Number297025
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/29/2020
Initial Report FDA Received Date08/28/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
Patient Age73 YR
-
-